These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1931567)

  • 1. Immunopathology of leprosy skin lesions.
    Rea TH; Modlin RL
    Semin Dermatol; 1991 Sep; 10(3):188-93. PubMed ID: 1931567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inside the skin: the local immune and inflammatory milieu in leprosy.
    Scollard DM
    Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy.
    Sunderkötter CH; Tomimori-Yamashita J; Nix V; Maeda SM; Sindrilaru A; Mariano M; Sorg C; Roth J
    Immunology; 2004 Apr; 111(4):472-80. PubMed ID: 15056385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells bearing V beta 6 T cell receptors in the cell-mediated immune response to Mycobacterium leprae.
    Wang X; Golkar L; Uyemura K; Ohmen JD; Villahermosa LG; Fajardo TT; Cellona RV; Walsh GP; Modlin RL
    J Immunol; 1993 Dec; 151(12):7105-16. PubMed ID: 8258714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients.
    Corbeau P; Desforges S; Bach MA
    Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time and change: new dimensions in the immunopathologic spectrum of leprosy.
    Scollard DM
    Ann Soc Belg Med Trop; 1993; 73 Suppl 1():5-11. PubMed ID: 8129479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
    Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
    J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of complement by circulating immune complexes isolated from leprosy patients.
    Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular leprosy of childhood and tuberculoid leprosy: a comparative, morphologic, immunopathologic and quantitative study of skin tissue reaction.
    Fakhouri R; Sotto MN; Manini MI; Margarido LC
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):218-26. PubMed ID: 14608817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase activity in leprosy.
    Suri Babu SS; Kannan KB; Katoch VM; Bharadwaj VP
    Indian J Lepr; 1990; 62(4):473-7. PubMed ID: 2086683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards understanding the pathology of erythema nodosum leprosum.
    Kahawita IP; Lockwood DN
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):329-37. PubMed ID: 18313706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity.
    Sieling PA; Jullien D; Dahlem M; Tedder TF; Rea TH; Modlin RL; Porcelli SA
    J Immunol; 1999 Feb; 162(3):1851-8. PubMed ID: 9973451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.